Company InformationInhibrx was founded on January 2017. The company is based in La Jolla, CA, USA . The number of employees in Inhibrx is less than 100. Inhibrx is a clinical-stage biotechnology company focused on developing a broad pipeline of novel biologic therapeutic candidates.
Here is how Inhibrx describes itself: "Anchored by our protein-engineering expertise and our proprietary single-domain antibody platform, we’ve developed a unique pipeline of therapeutic candidates."
Funding & investorsInhibrx has received 2 rounds of venture funding. The total funding amount is around $43.6M.
- Viking Global Investors (Private equity firm)
- Lilly Asia Ventures (Venture capital)
- RA Capital Management (Venture capital)
- Alexandria Venture (Venture capital)
- WuXi Biologics
- Contact us if you are interested to see all 7 investors
Similar Companies [beta]
Active Venture Investors
- Active Investors in Biotechnology
- Active Investors in Health Care
- Active Investors in Science And Engineering
- Active Investors in Wellness
- Best Funded Biotechnology Startups
- Best Funded Health Care Startups
- Best Funded Science And Engineering Startups
- Best Funded Wellness Startups
Inhibrx - Blog
- Hello world!
Welcome to WordPress. This is your first post. Edit or delete it, then start writing!The post Hello world! appeared first on Inhibrx.